BackLakewood-Amedex Biotherapeutics Overview

Lakewood-Amedex Biotherapeutics Common Stock

Lakewood-Amedex Biotherapeutics's common stock is $220.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$217.00

Peer trimmed avg / median

Loading

Lakewood-Amedex Biotherapeutics Common Stock History

Loading

Lakewood-Amedex Biotherapeutics vs. peers: Common Stock Comparison

Loading

Lakewood-Amedex Biotherapeutics Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Lakewood-Amedex Biotherapeutics (LABT) FAQ

Lakewood-Amedex Biotherapeutics's common stock stands at $220 as of June 2026. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Open the history chart to see whether Lakewood-Amedex Biotherapeutics's common stock is expanding or contracting. Sustained growth in common stock can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Lakewood-Amedex Biotherapeutics's common stock evolved across reporting periods, while the comparison chart places LABT next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, common stock is commonly used to spot outliers. Lakewood-Amedex Biotherapeutics's reading of $220 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.